Risk factors for development of superior limbic keratoconjunctivitis in thyroid eye disease in Japanese

[1]  Kaili Wu,et al.  Recharacterization of superior limbic keratoconjunctivitis via a subdividing grading method in 236 Chinese patients , 2022, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  Aric Vaidya,et al.  Changes in Eyelid Pressure and Dry Eye Status after Orbital Decompression in Thyroid Eye Disease , 2021, Journal of clinical medicine.

[3]  A. Kheirkhah,et al.  Superior Limbic Keratoconjunctivitis: A Comprehensive Review. , 2021, Survey of ophthalmology.

[4]  F. Sun,et al.  Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy , 2021, BioMed research international.

[5]  P. Lee,et al.  Tear film break-up patterns in thyroid eye disease , 2021, Scientific Reports.

[6]  K. Tsubota,et al.  Investigation of Meibomian Gland Function and Dry Eye Disease in Patients with Graves’ Ophthalmopathy † , 2020, Journal of clinical medicine.

[7]  Christopher Lo,et al.  Natural history of inflammatory and non-inflammatory dry eye in thyroid eye disease , 2020, Orbit.

[8]  Makoto Ito,et al.  Orbital Decompression for Exorbitism and Exophthalmos in a Patient With Thyroid Eye Disease. , 2020, The Journal of craniofacial surgery.

[9]  L. Bartalena,et al.  Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study , 2020, Journal of Endocrinological Investigation.

[10]  H. Kakizaki,et al.  Asymmetric lacrimal gland enlargement: an indicator for detection of pathological entities other than thyroid eye disease , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[11]  A. Rodríguez-Garcia,et al.  Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis , 2018, International Ophthalmology.

[12]  I. Cher.  Clinical Features of Superior Limbic Keratoconjunctivitis in Australia , 2016 .

[13]  F. Hu,et al.  In vivo confocal microscopy of bulbar conjunctiva in patients with Graves' ophthalmopathy. , 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

[14]  Ofira Zloto,et al.  Age differences in clinical manifestation and prognosis of thyroid eye disease , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  A. Fadlallah,et al.  Extensive superior limbic keratoconjunctivitis in Graves’ disease: case report and mini-review of the literature , 2015, Clinical ophthalmology.

[16]  S. Sikder,et al.  The relationship between Graves’ ophthalmopathy and dry eye syndrome , 2014, Clinical ophthalmology.

[17]  H. Kakizaki,et al.  Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease. , 2014, American journal of ophthalmology.

[18]  G. Kahaly,et al.  Neuroimaging of Graves' orbitopathy. , 2012, Best practice & research. Clinical endocrinology & metabolism.

[19]  W. Wiersinga,et al.  Graves' Orbitopathy: A Multidisciplinary Approach - Questions and Answers , 2010 .

[20]  D. Meyer,et al.  Eyelid retraction, lid lag, lagophthalmos, and von Graefe's sign quantifying the eyelid features of Graves' ophthalmopathy. , 2008, Ophthalmology.

[21]  J Lee,et al.  Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia , 2002, The British journal of ophthalmology.

[22]  T. Kanamoto,et al.  [Evaluation of extraocular muscle enlargement in dysthyroid ophthalmopathy]. , 2001, Nippon Ganka Gakkai zasshi.

[23]  R. Ziegler,et al.  Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption , 1996, Clinical endocrinology.

[24]  G. Bartley,et al.  Superior Limbic Keratoconjunctivitis , 2019, Contact Lens Complications.

[25]  W. Nunery,et al.  The Association of Cigarette Smoking with Clinical Subtypes of Ophthalmic Graves' Disease , 1993, Ophthalmic plastic and reconstructive surgery.

[26]  L Koornneef,et al.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. , 1989, The British journal of ophthalmology.

[27]  J. D. Nelson.  Superior limbic keratoconjunctivitis (SLK) , 1989, Eye.

[28]  Ostler Hb,et al.  Superior limbic keratoconjunctivitis. , 1986, International ophthalmology clinics.

[29]  I. Cher.  Clinical features of superior limbic keroconjunctivitis in Australia. A probable association withhyrotoxicosis. , 1969, Archives of ophthalmology.

[30]  M. Corwin.  Superior limbic keratoconjunctivitis. , 1968, American journal of ophthalmology.